Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ MXD1 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA541433

Catalog No. PIPA541433


Only null left
Add to Cart

Description

Description

Peptide sequence: MAAAVRMNIQ MLLEAADYLE RREREAEHGY ASMLPYNNKD RDALKRRNKS Sequence homology: Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%; Sheep: 92%; Zebrafish: 100%.

MAX dimerization protein belongs to a subfamily of MAX-interacting proteins. This protein competes with MYC for binding to MAX to form a sequence-specific DNA-binding complex, acts as a transcriptional repressor (while MYC appears to function as an activator) and is a candidate tumor suppressor.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

MXD1
Polyclonal
Unconjugated
MXD1
antagonizer of myc transcriptional activity; AW122478; BHLHC58; Mad; Mad1; Mad-1; max dimerization protein 1; Max dimerizer 1; MAX-binding protein; MGC104659; mxd1; OTTHUMP00000202211; Protein MAD; si:dkey-202n14.4
Rabbit
Affinity Chromatography
RUO
17119, 4084
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Western Blot, Surface Plasmon Resonance
0.5 mg/mL
PBS with 2% sucrose and 0.09% sodium azide
P50538, Q05195
MXD1
Synthetic peptide directed towards the N-terminal of human MXD1 (aa 1-50).
100 μL
Primary
Human, Mouse
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.